- Enrollment
- 32
- Started
- Mar 2022
- Completion
- Apr 2023
- Locations
- 10
- Countries
- 1
- Updated
- May 2024
Industry sponsor intelligence
H. Lundbeck A/SClinical Pipeline.
Lead-sponsor view of H. Lundbeck A/S's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 1
- Avg enrollment
- 32
Pipeline overview
Programs by phase and activity.
Velocity
H. Lundbeck A/S trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 41
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Calcitonin → | 1 | 0 | 0 | 0 | 1 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All H. Lundbeck A/S studies.
This page groups studies where H. Lundbeck A/S is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates